Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
To compare the independently assessed progression free survival of subjects with clear cell type renal cell carcinoma (all risk groups) treated with bevacizumab + temsirolimus (experimental) versus bevacizumab + interferon-alfa (control) in subjects with advanced renal cell carcinoma.
Inclusion criteria
- First-Line Treatment in Subjects with Advanced Renal Cell Carcinoma